[96a5a0]: / output / allTrials / identified / NCT03612466_identified.json

Download this file

389 lines (389 with data), 17.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
{
"info": {
"nct_id": "NCT03612466",
"official_title": "A Dose Finding Study of CycloSam® (153Sm-DOTMP) Combined With External Beam Radiotherapy to Treat High Risk Osteosarcoma and Other Solid Tumors Metastatic to Bone",
"inclusion_criteria": "* Histologically confirmed diagnosis of a solid tumor metastatic to bone, or a histologically confirmed diagnosis of osteosarcoma with either an unresectable primary tumor or metastases (including tumors with an intralesional resection).\n* Measurable disease on anatomic imaging that is also avid for phosphonate compounds as demonstrated by a positive 99mTc diphosphonate bone scan.\n* Adequate renal function, defined as a measured creatinine clearance >70 ml/min/1.73 m2 or normal radioisotope glomerular filtration rate (GFR).\n* Adequate hematologic function, defined as a platelet count > 50,000 cells/mm3 and an absolute neutrophil count (ANC) > 500 cells/mm3\n* Life expectancy of at least 8 weeks.\n* Karnofsky performance status > 50%\n* Subject must have adequately recovered from the effects of any prior chemotherapy, as determined by the treating physician and study team, based in part on organ function defined above. Toxicities from previous therapies must have recovered to Common Terminology Criteria for Adverse Events (CTCAE) 4.0 grade 2 or better.\n* Patients must have previously received effective treatment for their underlying disease and have no potentially curative options available.\nHealthy volunteers allowed\nMust have minimum age of 15 Years\nMust have maximum age of 65 Years",
"exclusion_criteria": "* Subject has received prior radiotherapy to all known areas of current active disease or has a known contraindication to receiving radiotherapy.\n* Subject is pregnant or breastfeeding.\n* Patient is sexually active and does not agree to use accepted, effective forms of contraception.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically confirmed diagnosis of a solid tumor metastatic to bone, or a histologically confirmed diagnosis of osteosarcoma with either an unresectable primary tumor or metastases (including tumors with an intralesional resection).",
"criterions": [
{
"exact_snippets": "Histologically confirmed diagnosis of a solid tumor metastatic to bone",
"criterion": "solid tumor metastatic to bone",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": "histologically confirmed"
}
]
},
{
"exact_snippets": "histologically confirmed diagnosis of osteosarcoma",
"criterion": "osteosarcoma",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": "histologically confirmed"
}
]
},
{
"exact_snippets": "osteosarcoma with either an unresectable primary tumor",
"criterion": "unresectable primary tumor",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "osteosarcoma with ... metastases",
"criterion": "metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "tumors with an intralesional resection",
"criterion": "intralesional resection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Measurable disease on anatomic imaging that is also avid for phosphonate compounds as demonstrated by a positive 99mTc diphosphonate bone scan.",
"criterions": [
{
"exact_snippets": "Measurable disease on anatomic imaging",
"criterion": "measurable disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "avid for phosphonate compounds",
"criterion": "avidity for phosphonate compounds",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "positive 99mTc diphosphonate bone scan",
"criterion": "99mTc diphosphonate bone scan",
"requirements": [
{
"requirement_type": "result",
"expected_value": "positive"
}
]
}
]
},
{
"line": "* Adequate renal function, defined as a measured creatinine clearance >70 ml/min/1.73 m2 or normal radioisotope glomerular filtration rate (GFR).",
"criterions": [
{
"exact_snippets": "Adequate renal function, defined as a measured creatinine clearance >70 ml/min/1.73 m2",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": ">",
"value": 70,
"unit": "ml/min/1.73 m2"
}
}
]
},
{
"exact_snippets": "Adequate renal function, defined as ... normal radioisotope glomerular filtration rate (GFR)",
"criterion": "radioisotope glomerular filtration rate (GFR)",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "normal"
}
]
}
]
},
{
"line": "* Adequate hematologic function, defined as a platelet count > 50,000 cells/mm3 and an absolute neutrophil count (ANC) > 500 cells/mm3",
"criterions": [
{
"exact_snippets": "Adequate hematologic function, defined as a platelet count > 50,000 cells/mm3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 50000,
"unit": "cells/mm3"
}
}
]
},
{
"exact_snippets": "Adequate hematologic function, defined as ... an absolute neutrophil count (ANC) > 500 cells/mm3",
"criterion": "absolute neutrophil count (ANC)",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 500,
"unit": "cells/mm3"
}
}
]
}
]
},
{
"line": "* Life expectancy of at least 8 weeks.",
"criterions": [
{
"exact_snippets": "Life expectancy of at least 8 weeks.",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 8,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Karnofsky performance status > 50%",
"criterions": [
{
"exact_snippets": "Karnofsky performance status > 50%",
"criterion": "Karnofsky performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 50,
"unit": "%"
}
}
]
}
]
},
{
"line": "* Subject must have adequately recovered from the effects of any prior chemotherapy, as determined by the treating physician and study team, based in part on organ function defined above. Toxicities from previous therapies must have recovered to Common Terminology Criteria for Adverse Events (CTCAE) 4.0 grade 2 or better.",
"criterions": [
{
"exact_snippets": "adequately recovered from the effects of any prior chemotherapy",
"criterion": "recovery from prior chemotherapy",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "Toxicities from previous therapies must have recovered to Common Terminology Criteria for Adverse Events (CTCAE) 4.0 grade 2 or better",
"criterion": "toxicities from previous therapies",
"requirements": [
{
"requirement_type": "recovery",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "CTCAE 4.0 grade"
}
}
]
}
]
},
{
"line": "* Patients must have previously received effective treatment for their underlying disease and have no potentially curative options available.",
"criterions": [
{
"exact_snippets": "Patients must have previously received effective treatment for their underlying disease",
"criterion": "previous treatment for underlying disease",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": true
}
]
},
{
"exact_snippets": "have no potentially curative options available",
"criterion": "curative options",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 15 Years",
"criterions": [
{
"exact_snippets": "minimum age of 15 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 15,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 65 Years",
"criterions": [
{
"exact_snippets": "maximum age of 65 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 65,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Subject has received prior radiotherapy to all known areas of current active disease or has a known contraindication to receiving radiotherapy.",
"criterions": [
{
"exact_snippets": "Subject has received prior radiotherapy to all known areas of current active disease",
"criterion": "prior radiotherapy to all known areas of current active disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "has a known contraindication to receiving radiotherapy",
"criterion": "contraindication to receiving radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Subject is pregnant or breastfeeding.",
"criterions": [
{
"exact_snippets": "Subject is pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breastfeeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patient is sexually active and does not agree to use accepted, effective forms of contraception.",
"criterions": [
{
"exact_snippets": "Patient is sexually active",
"criterion": "sexual activity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "does not agree to use accepted, effective forms of contraception",
"criterion": "contraception agreement",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}